MP
AEHAU

Mangrove Partners’s Aesther Healthcare Acquisition Corp Units AEHAU Stock Holding History

Mangrove Partners’s Portfolio AEHAU Stock Details AEHAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$2.02M – 599
2021
Q4 		$2.02M Hold
200,000
– – 0.12% 258
2021
Q3 		$2.03M Buy
+200,000
New +$2.02M 0.18% 167

Other funds holding AEHAU

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mangrove Partners's AEHAU Position: Q1 2022 in Review

Mangrove Partners sold out of Aesther Healthcare Acquisition Corp Units (AEHAU) in Q1 2022, closing a stake of 200,000 shares — an estimated $2.02M sold.

Mangrove Partners first reported a position in AEHAU in Q3 2021 and held it in 2 quarters. The position peaked at $2.03M in Q3 2021. 7 funds tracked by Wall St. Rank hold AEHAU as of Q1 2022.

  • Mangrove Partners reported no remaining Aesther Healthcare Acquisition Corp Units position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 200,000 Aesther Healthcare Acquisition Corp Units shares in Q1 2022, an estimated $2.02M.
  • Mangrove Partners first reported a position in Aesther Healthcare Acquisition Corp Units in Q3 2021 and held it in 2 quarters.
  • Mangrove Partners's Aesther Healthcare Acquisition Corp Units position peaked at $2.03M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Aesther Healthcare Acquisition Corp Units as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.